Guidelines* for diagnosis and therapy of venous ulcers (version 8 2008) - ICD10: 183.0 (without inflammation) and 183.2 (with inflammation)

Phlebologie

Volumn 37, Issue 6, 2008, Pages 308-329

  Rabe, Eberhard ^a   Marshall, Markard ^b   Marshall, Markward ^c   Schimmelpfennig, Lutz ^d,e   Gerlach, Horst ^f   Stücker, Markus ^g   Gallenkemper, Georg ^h,w   Hermanns, Hans Joachim ^h   Jünger, Michael ⁱ   Noppeney, Thomas ^j   Wienert, Volker ^k   Stenger, Dietmar ^l   Blazek, Vladimir ^m   Breu, Franz Xaver ^l   Ehresmann, Uwe ⁿ   Hertel, Thomas ^l   Kahle, Birgit ^o   Kluess, Holger ^p   Pannier, Felizitas ^q   Schwahn Schreiber, Christine ^r   Stege, Helger ^s   Waldermann, Franz ^l   Hartmann, Karsten ^t,u   Proebstle, Thomas ^v   more..

^a UNIVERSITY HOSPITAL BONN   (Germany)

^b Praxisklinik Sauerlach   (Germany)

^c Steigerwaldklinik Burgebrach ^*  (Germany)

^d Chirurgischen Abteilung der Steigerwaldklinik Burgebrach   (Germany)

^e Chirurgischen Abteilung   (Germany)

^f Gemeinschaftspraxis Für Gefäßmedizin ^*  (Germany)

^g ST JOSEF HOSPITAL   (Germany)

^h Gemeinschaftspraxis Für Gefäßmedizin   (Germany)

ⁱ UNIVERSITY OF GREIFSWALD   (Germany)

^j Klinik/Praxis Oberwald ^*  (Germany)

^k RWTH AACHEN UNIVERSITY   (Germany)

^l Univ Hautklinik ^*  (Germany)

^m RWTH AACHEN UNIVERSITY   (Germany)

ⁿ Klinik Praxis Oberwald

^o Klinik fur Dermatologie   (Germany)

^p NONE   (Germany)

^q NONE   (Germany)

^r NONE   (Germany)

^s UNIVERSITY HOSPITAL DÜSSELDORF   (Germany)

^t NONE   (Germany)

^u NONE   (Germany)

^v Proaesthetic Klinik Heidelberg   (Germany)

^w Expertenkommission Zur Leitlinie   (Germany)

more..

Author keywords

German Society of Phlebology; Guidelines; Venous ulcer

Indexed keywords

ACETYLSALICYLIC ACID; AMELOGENIN; ASCORBIC ACID; BLOOD CLOTTING FACTOR 13; CENTELLA ASIATICA EXTRACT; CLOPIDOGREL; CORTICOSTEROID; COUMARIN; DAFLON; DALTEPARIN; DEFIBROTIDE; EPIDERMAL GROWTH FACTOR; GINKGO BILOBA EXTRACT; HEPARIN; ILOPROST; NAFTAZONE; PENTOXIFYLLINE; PLACEBO; PLATELET DERIVED GROWTH FACTOR; PROSTAGLANDIN E1; REPIFERMIN; RUSCUS EXTRACT; SALAZOSULFAPYRIDINE; STANOZOLOL; SULODEXIDE; TRANSFORMING GROWTH FACTOR BETA1; TRIBENOSIDE; TROXERUTIN; UNINDEXED DRUG; VASCULOTROPIN;

AGING; ALLERGIC REACTION; ANXIETY; BODY IMAGE; CELL TRANSPLANTATION; CHRONIC VEIN INSUFFICIENCY; CLINICAL ASSESSMENT; CLINICAL TRIAL; COMPRESSION GARMENT; COMPRESSION THERAPY; COST BENEFIT ANALYSIS; COST EFFECTIVENESS ANALYSIS; DEBRIDEMENT; DEPRESSION; DIFFERENTIAL DIAGNOSIS; DRUG EFFECT; ELECTROMAGNETIC FIELD; EVIDENCE BASED MEDICINE; FASCIOCUTANEOUS FLAP; FASCIOTOMY; FIBRINOLYSIS; FOLLOW UP; HEALTH CARE COST; HEPARINIZATION; HUMAN; HYPERBARIC OXYGEN; HYPODERMATITIS; KERATINOCYTE; LOCAL THERAPY; LOW DRUG DOSE; LOW LEVEL LASER THERAPY; LYMPHATIC DRAINAGE; MYOCUTANEOUS FLAP; PATHOPHYSIOLOGY; PHOTOTHERAPY; PHYSIOTHERAPY; POSTTHROMBOSIS SYNDROME; PRACTICE GUIDELINE; PREVALENCE; PULSED ELECTRIC FIELD; QUALITY OF LIFE; RECURRENT DISEASE; REVIEW; SCLEROTHERAPY; SEX DIFFERENCE; SKIN INFLAMMATION; SKIN TRANSPLANTATION; SOCIAL SUPPORT; SOCIOECONOMICS; SURGICAL APPROACH; SURGICAL RISK; THROMBOEMBOLISM; TISSUE NECROSIS; TREATMENT DURATION; ULCER; ULCER HEALING; VARICOSIS; VASCULITIS; VEIN RECONSTRUCTION; VEIN TRANSPLANTATION; WORK CAPACITY; WOUND DRESSING; WOUND INFECTION;

EID: 58149465734     PISSN: 0939978X     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-0037-1622246     Document Type: Review

References (0)